How to improve the early diagnosis of Trypanosoma cruzi infection: relationship between validated conventional diagnosis and quantitative DNA amplification in congenitally infected children.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 3798617)

Published in PLoS Negl Trop Dis on October 17, 2013

Authors

Jacqueline Bua1, Bibiana J Volta, Alina E Perrone, Karenina Scollo, Elsa B Velázquez, Andres M Ruiz, Ana M De Rissio, Rita L Cardoni

Author Affiliations

1: Instituto Nacional de Parasitología (INP) Dr. M. Fatala Chaben, Paseo Colón 568 (1063), Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) Buenos Aires, Argentina.

Articles cited by this

DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Mol Biochem Parasitol (1996) 2.90

American trypanosomiasis (Chagas disease). Infect Dis Clin North Am (2012) 2.04

Congenital parasitic infections: a review. Acta Trop (2011) 1.88

Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients. PLoS Negl Trop Dis (2009) 1.85

Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis (2009) 1.81

Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am J Trop Med Hyg (2004) 1.69

Vertical transmission of Trypanosoma cruzi infection: quantification of parasite burden in mothers and their children by parasite DNA amplification. Trans R Soc Trop Med Hyg (2012) 1.65

Analytical performance of a multiplex Real-Time PCR assay using TaqMan probes for quantification of Trypanosoma cruzi satellite DNA in blood samples. PLoS Negl Trop Dis (2013) 1.52

Direct molecular profiling of minicircle signatures and lineages of Trypanosoma cruzi bloodstream populations causing congenital Chagas disease. Int J Parasitol (2007) 1.44

High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina. Pediatrics (2005) 1.35

Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in north-western Argentina. Trop Med Int Health (2000) 1.33

Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg (1998) 1.24

Sensitive detection and strain classification of Trypanosoma cruzi by amplification of a ribosomal RNA sequence. Mol Biochem Parasitol (1993) 1.19

Comparison of Trypanosoma cruzi lineages and levels of parasitic DNA in infected mothers and their newborns. Am J Trop Med Hyg (2007) 1.10

[Trypanosoma cruzi transplacental infection: situation in Chile]. Rev Med Chil (2001) 1.04

Congenital Chagas disease involves Trypanosoma cruzi sub-lineage IId in the northwestern province of Salta, Argentina. Infect Genet Evol (2008) 0.99

Risk factors and consequences of congenital Chagas disease in Yacuiba, south Bolivia. Trop Med Int Health (2007) 0.97

[A retrospective search for maternal transmission of Chagas infection from patients in the chronic phase]. Rev Soc Bras Med Trop (2005) 0.94

Congenital Trypanosoma cruzi infection. Efficacy of its monitoring in an urban reference health center in a non-endemic area of Argentina. Am J Trop Med Hyg (2010) 0.94

Door-to-door screening as a strategy for the detection of congenital Chagas disease in rural Bolivia. Trop Med Int Health (2011) 0.91

[Maternal-fetal transmission of Trypanosoma cruzi in Argentina]. Medicina (B Aires) (2009) 0.89

Presence of Trypanosoma cruzi in pregnant women and typing of lineages in congenital cases. Acta Trop (2012) 0.88

Prevalence of Chagas disease in pregnant women and incidence of congenital transmission in Santa Cruz de la Sierra, Bolivia. Acta Trop (2012) 0.85

The epidemiological relevance of family study in Chagas disease. PLoS Negl Trop Dis (2013) 0.82

Articles by these authors

Vertical transmission of Trypanosoma cruzi infection: quantification of parasite burden in mothers and their children by parasite DNA amplification. Trans R Soc Trop Med Hyg (2012) 1.65

Conversion from mycophenolate mofetil to delayed formulation in pediatric renal transplantation: higher mycophenolic acid predose level but no changes in the immune biomarkers. Pediatr Transplant (2009) 1.40

[Maternal-fetal transmission of Trypanosoma cruzi in Argentina]. Medicina (B Aires) (2009) 0.89

Trypanosoma cruzi-specific immune responses in subjects from endemic areas of Chagas disease of Argentina. Microbes Infect (2010) 0.85

Trypanosoma cruzi: biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs. Exp Parasitol (2010) 0.82

Conversion from cyclosporine A to tacrolimus in pediatric kidney transplant recipients with chronic rejection: changes in the immune responses. Transplantation (2004) 0.80

Benzonidazole therapy modulates interferon-γ and M2 muscarinic receptor autoantibody responses in Trypanosoma cruzi-infected children. PLoS One (2011) 0.80

Soluble tumor necrosis factor (TNF) receptors (sTNF-R1 and -R2) in pregnant women chronically infected with Trypanosoma cruzi and their children. Am J Trop Med Hyg (2008) 0.78

Mycophenolate mofetil and reduced doses of cyclosporine in pediatric liver transplantation with chronic renal dysfunction: changes in the immune responses. Pediatr Transplant (2004) 0.76

Trypanosoma cruzi: the expansion of NK, T, and NKT cells in the experimental infection. Exp Parasitol (2004) 0.75